PRME:NASDAQ, Prime Medicine, Inc.

PRME stock overview

Prime Medicine, Inc. (PRME:NASDAQ) closed at $3.55 on November 20, 2026, down 7.55% on the day. The stock trades 39.9% below its 52-week high of $5.91 and 33.0% above its 52-week low of $2.67. Over the past year, it lost 6.3%. Prime Medicine, Inc. is part of the Health Care sector.

Key figures

Price
$3.55
Day change
-7.55%
Volume
6,127,162
Average volume
4,599,746
Market cap
791M+
52-week range
$2.67 – $5.91
50-day average
$3.73
200-day average
$3.51

Price action over the past year

In 252 trading sessions since November 20, 2025, PRME closed higher on 112 days (44%). Its best day was October 28, 2026 (+23.22%) and its worst was June 5, 2026 (-11.82%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

PRME news

About Prime Medicine, Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.

Similar stocks

Find more stocks like PRME with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.